Susquehanna International Group’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $397K | Buy |
93,095
+21,307
| +30% | +$90.8K | ﹤0.01% | 4646 |
|
|
2025
Q1 | $270K | Buy |
71,788
+5,568
| +8% | +$20.9K | ﹤0.01% | 5150 |
|
|
2024
Q4 | $386K | Buy |
66,220
+19,952
| +43% | +$116K | ﹤0.01% | 4430 |
|
|
2024
Q3 | $552K | Sell |
46,268
-19,870
| -30% | -$237K | ﹤0.01% | 3513 |
|
|
2024
Q2 | $716K | Buy |
66,138
+18,102
| +38% | +$196K | ﹤0.01% | 2990 |
|
|
2024
Q1 | $544K | Sell |
48,036
-103,831
| -68% | -$1.18M | ﹤0.01% | 3429 |
|
|
2023
Q4 | $2.13M | Buy |
151,867
+116,874
| +334% | +$1.64M | ﹤0.01% | 1874 |
|
|
2023
Q3 | $432K | Buy |
34,993
+24,921
| +247% | +$308K | ﹤0.01% | 3614 |
|
|
2023
Q2 | $91K | Sell |
10,072
-77,944
| -89% | -$704K | ﹤0.01% | 5038 |
|
|
2023
Q1 | $305K | Buy |
+88,016
| New | +$305K | ﹤0.01% | 4398 |
|
|
2022
Q4 | – | Sell |
-12,622
| Closed | -$35K | – | 6496 |
|
|
2022
Q3 | $35K | Sell |
12,622
-14,548
| -54% | -$40.3K | ﹤0.01% | 5600 |
|
|
2022
Q2 | $111K | Sell |
27,170
-14,251
| -34% | -$58.2K | ﹤0.01% | 4955 |
|
|
2022
Q1 | $176K | Sell |
41,421
-249,833
| -86% | -$1.06M | ﹤0.01% | 4904 |
|
|
2021
Q4 | $2.73M | Buy |
+291,254
| New | +$2.73M | ﹤0.01% | 1665 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5845 |
|
|
2021
Q2 | – | Sell |
-43,254
| Closed | -$1.44M | – | 5735 |
|
|
2021
Q1 | $1.44M | Buy |
43,254
+155
| +0.4% | +$5.14K | ﹤0.01% | 2516 |
|
|
2020
Q4 | $2.07M | Buy |
+43,099
| New | +$2.07M | ﹤0.01% | 1696 |
|